OBI Pharma

@obipharma.bsky.social

3 months ago

🤝浩鼎與美國 TegMine Therapeutics 簽訂受其委託開發之醣蛋白 ADC 全球專屬授權合約
🌏此次國際授權合作，展現以浩鼎 Obrion™ ADC 技術所開發產品的應用前景🚀
#OBIPharma #Obrion #GlycOBI #Glycoprotein #ADC #ExclusiveLicense #GlobalPartnership

www.obipharma.com/zh-hant/news...

OBI Pharma

@obipharma.bsky.social

9 months ago

🔬 2025 Annual General Meeting｜Strategy, Innovation, and Out-Licensing
At our 2025 AGM, OBI Pharma reaffirmed its strategic focus on Antibody-Drug Conjugates (ADCs).
#ADC #OBIPharma #AGM2025 #PrecisionMedicine #DrugDevelopment #Obrion
www.obipharma.com/news/innovat...